Related Experiment Videos

Hematological and biochemical studies in children with Down syndrome

B Ibarra1, F Rivas, C Medina

  • 1División de Genética, Hospital de Especialidades del Centro Médico de Occidente, IMSS, Guadalajara, Jalisco, Mexico.

Annales De Genetique
|January 1, 1990
PubMed

Insights

Children with Down syndrome often exhibit macrocytosis and elevated red blood cell enzymes like adenosine deaminase (ADA) and glucose-6-phosphate dehydrogenase (G6PD), suggesting a potential link between these factors.

Area of Science:

  • Hematology
  • Biochemistry
  • Genetics

Background:

  • Down syndrome is a genetic disorder associated with various health complications.
  • Hematological and biochemical profiles in children with Down syndrome require further investigation.

Purpose of the Study:

  • To investigate hematological and biochemical parameters in children with Down syndrome.
  • To compare these parameters with a control group of normal children.
  • To explore potential associations between specific findings.

Main Methods:

  • Hematological and biochemical analyses were performed on 83 children with Down syndrome and 69 controls.
  • Key variables included hemoglobin variants (HbF, HbA2), vitamin B12, folates, iron studies, hematic cytology, and red blood cell enzymes (ADA, G6PD, SOD).

Main Results:

  • Children with Down syndrome showed macrocytosis and normal leukocyte counts.
  • Elevated levels of fetal hemoglobin (HbF), vitamin B12, folates, adenosine deaminase (ADA), and glucose-6-phosphate dehydrogenase (G6PD) were observed.
  • Normal levels of HbA2 and superoxide dismutase (SOD) were found.

Conclusions:

  • Children with Down syndrome present with characteristic hematological and biochemical differences, including macrocytosis and increased ADA and G6PD activity.
  • An indirect association between macrocytosis and elevated ADA and G6PD levels is suggested.
  • Further research is warranted to elucidate the underlying mechanisms.

Related Concept Videos